Follow
Manju Y Krishnan
Manju Y Krishnan
Verified email at cdri.res.in
Title
Cited by
Cited by
Year
Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis
S Singh, KK Roy, SR Khan, VK Kashyap, A Sharma, S Jaiswal, ...
Bioorganic & Medicinal Chemistry 23 (4), 742-752, 2015
622015
Triacylglycerols: Fuelling the Hibernating Mycobacterium tuberculosis
RK Maurya, S Bharti, MY Krishnan
Frontiers in cellular and infection microbiology 8, 450, 2019
602019
In vitro antimicrobial activities of capuramycin analogues against non-tuberculous mycobacteria
T Dubuisson, E Bogatcheva, MY Krishnan, MT Collins, L Einck, CA Nacy, ...
Journal of antimicrobial chemotherapy 65 (12), 2590-2597, 2010
502010
Comparison of three methods for susceptibility testing of Mycobacterium avium subsp. paratuberculosis to 11 antimicrobial drugs
MY Krishnan, EJB Manning, MT Collins
Journal of Antimicrobial Chemotherapy 64 (2), 310-316, 2009
442009
Biological evaluation of novel substituted chloroquinolines targeting mycobacterial ATP synthase
SR Khan, S Singh, KK Roy, MS Akhtar, AK Saxena, MY Krishnan
International journal of antimicrobial agents 41 (1), 41-46, 2013
402013
Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus
H Shukla, V Kumar, AK Singh, S Rastogi, SR Khan, MI Siddiqi, ...
International journal of biological macromolecules 78, 137-141, 2015
392015
Mycobacterium tuberculosis persistence in various adipose depots of infected mice and the effect of anti-tubercular therapy
P Agarwal, SR Khan, SC Verma, M Beg, K Singh, K Mitra, AN Gaikwad, ...
Microbes and Infection 16 (7), 571-580, 2014
342014
Down-regulation of PE11, a cell wall associated esterase, enhances the biofilm growth of Mycobacterium tuberculosis and reduces cell wall virulence lipid levels
S Rastogi, AK Singh, G Pant, K Mitra, KV Sashidhara, MY Krishnan
Microbiology 163 (1), 52-61, 2017
332017
Effects of interactions of antibacterial drugs with each other and with 6-mercaptopurine on in vitro growth of Mycobacterium avium subspecies paratuberculosis
MY Krishnan, EJB Manning, MT Collins
Journal of antimicrobial chemotherapy 64 (5), 1018-1023, 2009
322009
Use of an adipocyte model to study the transcriptional adaptation of Mycobacterium tuberculosis to store and degrade host fat
S Rastogi, P Agarwal, MY Krishnan
The International Journal of Mycobacteriology 5 (1), 92-98, 2016
252016
Insight into the structural flexibility and function of Mycobacterium tuberculosis isocitrate lyase
H Shukla, V Kumar, AK Singh, N Singh, M Kashif, MI Siddiqi, MY Krishnan, ...
Biochimie 110, 73-80, 2015
232015
Insights into the mechanism of action of hyaluronate lyase: role of C-terminal domain and Ca2+ in the functional regulation of enzyme
MS Akhtar, MY Krishnan, V Bhakuni
Journal of biological chemistry 281 (38), 28336-28344, 2006
212006
Synthesis and anti-tubercular activity of conformationally-constrained and bisquinoline analogs of TMC207
D Kalia, AK KS, G Meena, KP Sethi, R Sharma, P Trivedi, SR Khan, ...
MedChemComm 6 (8), 1554-1563, 2015
182015
Alternate pathway to ascorbate induced inhibition of Mycobacterium tuberculosis
H Shukla, SR Khan, R Shukla, MY Krishnan, MS Akhtar, T Tripathi
Tuberculosis 111, 161-169, 2018
162018
Mycobacterium tuberculosis can gain access to adipose depots of mice infected via the intra-nasal route and to lungs of mice with an infected subcutaneous fat implant
P Agarwal, P Pandey, J Sarkar, MY Krishnan
Microbial pathogenesis 93, 32-37, 2016
162016
Primary mouse lung fibroblasts help macrophages to tackle Mycobacterium tuberculosis more efficiently and differentiate into myofibroblasts up on bacterial stimulation
SC Verma, P Agarwal, MY Krishnan
Tuberculosis 97, 172-180, 2016
142016
The diacylglycerol acyltransferase Rv3371 of Mycobacterium tuberculosis is required for growth arrest and involved in stress-induced cell wall alterations
S Rastogi, AK Singh, G Chandra, P Kushwaha, G Pant, K Singh, K Mitra, ...
Tuberculosis 104, 8-19, 2017
122017
Combined use of Amplified Fragment Length Polymorphism and IS6110 -RFLP in fingerprinting clinical isolates of Mycobacterium tuberculosis from Kerala, South …
MY Krishnan, I Radhakrishnan, BV Joseph, ML Gk, A Kumar R, ...
BMC Infectious Diseases 7, 1-5, 2007
122007
Rv1717 Is a Cell Wall - Associated β-Galactosidase of Mycobacterium tuberculosis That Is Involved in Biofilm Dispersion
S Bharti, RK Maurya, U Venugopal, R Singh, MS Akhtar, MY Krishnan
Frontiers in Microbiology 11, 611122, 2021
102021
Effect of various drugs on differentially detectable persisters of Mycobacterium tuberculosis generated by long-term lipid diet
SR Khan, U Venugopal, G Chandra, S Bharti, RK Maurya, MY Krishnan
Tuberculosis 115, 89-95, 2019
82019
The system can't perform the operation now. Try again later.
Articles 1–20